+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Peptide Synthesis Market by Product (Equipment, Reagents, Services), Technology (Hybrid & Recombinant Technology, Solid-Phase Peptide Synthesis, Solution-Phase Synthesis), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 180 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4896703
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Peptide Synthesis Market size was estimated at USD 636.71 million in 2023, USD 683.44 million in 2024, and is expected to grow at a CAGR of 7.84% to reach USD 1,080.42 million by 2030.

Peptide synthesis is a complex and advanced chemical process that entails the formation of peptides, which are short chains of amino acids linked by peptide bonds. These peptides play several critical roles in various biological systems, including signaling, regulation of cellular processes, and maintaining structural components. The technique involves adding amino acids to a growing polypeptide chain stepwise while protecting specific functional groups and ensuring high fidelity throughout the process. There is a higher demand for peptide therapeutics due to their increased applications, and pharmaceutical research activities and funding are on the rise across various economies. Moreover, the cosmetics industry is experiencing a growing need for bioactive peptides, contributing to increased peptide synthesis adoption. The lack of standardized rules and regulations for peptide design and difficulties in peptide production hinders its usage. However, the introduction of advanced peptide synthesizers and technologies developed for peptide design and the potential utilization of peptides in nutraceuticals and food preservation is expected to boost their synthesis in the future.

Regional Insights

Peptide synthesis is a crucial technique in the field of biochemistry and pharmaceutical research across the Americas. In North America, the United States holds a dominant position in peptide synthesis usage due to its well-established biopharmaceutical industry, extensive research infrastructure, and considerable investment in life sciences. In South America, countries such as Brazil and Mexico are witnessing increased adoption of peptide synthesis technologies due to expanding biotechnology sectors and governmental support towards research initiatives. The Asia-Pacific peptide synthesis market's robust growth can be attributed to increased R&D investments by governments and private entities, surging demand for novel therapeutic solutions, expanding pharmaceutical & biotechnology industries' footprint within the region, and a thriving CRO landscape. The peptide synthesis market in the EMEA region is experiencing significant growth, driven by technological advancements in synthesizers, increased funding for research and development activities, and a growing demand for synthetic peptides in pharmaceuticals, biotechnology, and other industries. The market has witnessed an influx of new players and collaborations among existing participants to develop innovative technologies for peptide synthesis.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Peptide Synthesis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Peptide Synthesis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Peptide Synthesis Market, highlighting leading vendors and their innovative profiles. These include 2B Scientific Limited, AAPPTec, ABclonal, Inc., Advanced ChemTech, Almac Group Limited, AmbioPharm Inc., AnaSpec Inc., Bachem AG, Biocon Limited, Biosynth Ltd., Biotage, CEM Corporation, CPC Scientific Inc., Creative Diagnostics, Creative Peptides, CSBio, Enamine Ltd., GenScript Biotech Corporation, Gyros Protein Technologies AB, Hybio Pharmaceutical Co., Ltd., JPT Peptide Technologies GmbH by TheraCode GmbH, Kaneka Corporation, LifeTein LLC, Merck KGaA, New England BioGroup, LLC, Novo Nordisk A/S, PolyPeptide Group AG, Thermo Fisher Scientific Inc., and USV Private Limited.

Market Segmentation & Coverage

This research report categorizes the Peptide Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Equipment
      • Chromatography Equipment
      • Lyophilizers
      • Peptide Synthesizers
    • Reagents
      • Amino Acids
      • Base Resins
      • Peptide Coupling Reagents
      • Peptide Labeling Reagents
    • Services
  • Technology
    • Hybrid & Recombinant Technology
    • Solid-Phase Peptide Synthesis
    • Solution-Phase Synthesis
  • End User
    • Academic & Research Institutes
    • Contract Development & Manufacturing Organization/Contract Research Organization
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Peptide Synthesis Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Peptide Synthesis Market?
  3. What are the technology trends and regulatory frameworks in the Peptide Synthesis Market?
  4. What is the market share of the leading vendors in the Peptide Synthesis Market?
  5. Which modes and strategic moves are suitable for entering the Peptide Synthesis Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Peptide Synthesis Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Higher need and applications of peptide therapeutics
5.1.1.2. Increase in pharmaceutical research activities and funding across economies
5.1.1.3. Growing demand for bioactive peptides from the cosmetics industry
5.1.2. Restraints
5.1.2.1. Lack of standard peptide design rules and regulations
5.1.3. Opportunities
5.1.3.1. Development of advanced peptide synthesizers and technologies for peptide design
5.1.3.2. Emerging applications of peptides in nutraceuticals and food preservation
5.1.4. Challenges
5.1.4.1. Difficulty in development of peptides and instability of the peptides
5.2. Market Segmentation Analysis
5.2.1. Product: Growing usage of reagents for forming peptide bonds during synthesis
5.2.2. Technology: Rising potential of hybris & recombinant technology as it offers high peptide yield and purity
5.2.3. End-User: Expanding usage of peptide synthesis by pharmaceutical & biopharmaceutical companies for drug discovery
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Peptide Synthesis Market, by Product
6.1. Introduction
6.2. Equipment
6.3.1. Chromatography Equipment
6.3.2. Lyophilizers
6.3.3. Peptide Synthesizers
6.3. Reagents
6.4.1. Amino Acids
6.4.2. Base Resins
6.4.3. Peptide Coupling Reagents
6.4.4. Peptide Labeling Reagents
6.4. Services
7. Peptide Synthesis Market, by Technology
7.1. Introduction
7.2. Hybrid & Recombinant Technology
7.3. Solid-Phase Peptide Synthesis
7.4. Solution-Phase Synthesis
8. Peptide Synthesis Market, by End User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Contract Development & Manufacturing Organization/Contract Research Organization
8.4. Pharmaceutical & Biotechnology Companies
9. Americas Peptide Synthesis Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Peptide Synthesis Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Peptide Synthesis Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Biosynth Extends Peptide Synthesis Offering With Pepceuticals Acquisition
12.3.1.2. Mesa Labs Acquires Belyntic’s Peptide Purification Business
12.3.2. Award, Recognition, & Expansion
12.3.2.1. GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 2B Scientific Limited
13.1.2. AAPPTec
13.1.3. ABclonal, Inc.
13.1.4. Advanced ChemTech
13.1.5. Almac Group Limited
13.1.6. AmbioPharm Inc.
13.1.7. AnaSpec Inc.
13.1.8. Bachem AG
13.1.9. Biocon Limited
13.1.10. Biosynth Ltd.
13.1.11. Biotage
13.1.12. CEM Corporation
13.1.13. CPC Scientific Inc.
13.1.14. Creative Diagnostics
13.1.15. Creative Peptides
13.1.16. CSBio
13.1.17. Enamine Ltd.
13.1.18. GenScript Biotech Corporation
13.1.19. Gyros Protein Technologies AB
13.1.20. Hybio Pharmaceutical Co., Ltd.
13.1.21. JPT Peptide Technologies GmbH by TheraCode GmbH
13.1.22. Kaneka Corporation
13.1.23. LifeTein LLC
13.1.24. Merck KGaA
13.1.25. New England BioGroup, LLC
13.1.26. Novo Nordisk A/S
13.1.27. PolyPeptide Group AG
13.1.28. Thermo Fisher Scientific Inc.
13.1.29. USV Private Limited
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. PEPTIDE SYNTHESIS MARKET RESEARCH PROCESS
FIGURE 2. PEPTIDE SYNTHESIS MARKET SIZE, 2023 VS 2030
FIGURE 3. PEPTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PEPTIDE SYNTHESIS MARKET DYNAMICS
FIGURE 7. PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. PEPTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PEPTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 8. PEPTIDE SYNTHESIS MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PEPTIDE SYNTHESIS MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 13. PEPTIDE SYNTHESIS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PEPTIDE SYNTHESIS MARKET SIZE, BY BASE RESINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE COUPLING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE LABELING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PEPTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 19. PEPTIDE SYNTHESIS MARKET SIZE, BY HYBRID & RECOMBINANT TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PEPTIDE SYNTHESIS MARKET SIZE, BY SOLID-PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. PEPTIDE SYNTHESIS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. PEPTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PEPTIDE SYNTHESIS MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION/CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. PEPTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 44. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 45. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 46. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 49. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 50. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 71. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 72. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 76. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 77. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 86. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 87. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 116. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 117. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 132. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 133. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 137. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 138. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 142. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 143. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 147. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 148. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 152. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 153. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 162. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 163. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 177. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 178. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 182. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 183. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 187. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 188. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 207. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 222. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 223. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 236. PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 237. PEPTIDE SYNTHESIS MARKET LICENSE & PRICING

Companies Mentioned

  • 2B Scientific Limited
  • AAPPTec
  • ABclonal, Inc.
  • Advanced ChemTech
  • Almac Group Limited
  • AmbioPharm Inc.
  • AnaSpec Inc.
  • Bachem AG
  • Biocon Limited
  • Biosynth Ltd.
  • Biotage
  • CEM Corporation
  • CPC Scientific Inc.
  • Creative Diagnostics
  • Creative Peptides
  • CSBio
  • Enamine Ltd.
  • GenScript Biotech Corporation
  • Gyros Protein Technologies AB
  • Hybio Pharmaceutical Co., Ltd.
  • JPT Peptide Technologies GmbH by TheraCode GmbH
  • Kaneka Corporation
  • LifeTein LLC
  • Merck KGaA
  • New England BioGroup, LLC
  • Novo Nordisk A/S
  • PolyPeptide Group AG
  • Thermo Fisher Scientific Inc.
  • USV Private Limited

Methodology

Loading
LOADING...

Table Information